We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,113 hedge funds and large institutions have $48.7B invested in Thermo Fisher Scientific in 2016 Q4 according to their latest regulatory filings, with 141 funds opening new positions, 388 increasing their positions, 434 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 55

7% more funds holding

Funds holding: 1,0441,113 (+69)

1.33% less ownership

Funds ownership: 88.67%87.34% (-1.3%)

11% less repeat investments, than reductions

Existing positions increased: 388 | Existing positions reduced: 434

12% less capital invested

Capital invested by funds: $55.2B → $48.7B (-$6.44B)

35% less funds holding in top 10

Funds holding in top 10: 9360 (-33)

46% less call options, than puts

Call options by funds: $123M | Put options by funds: $228M

Holders
1,113
Holders Change
+69
Holders Change %
+6.61%
% of All Funds
27.82%
Holding in Top 10
60
Holding in Top 10 Change
-33
Holding in Top 10 Change %
-35.48%
% of All Funds
1.5%
New
141
Increased
388
Reduced
434
Closed
55
Calls
$123M
Puts
$228M
Net Calls
-$105M
Net Calls Change
-$130M
Name Holding Trade Value Shares
Change
Change in
Stake
BRCM
601
Bright Rock Capital Management
Massachusetts
$1.98M
LRIC
602
Long Road Investment Counsel
Michigan
$1.97M
MIM
603
Marco Investment Management
Georgia
$1.96M
AC
604
Allstate Corporation
Illinois
$1.94M -$2.56M -17,374 -56%
Thrivent Financial for Lutherans
605
Thrivent Financial for Lutherans
Minnesota
$1.94M +$130K +880 +7%
LBC
606
Lawrence B. Cohen
$1.94M -$75.3K -511 -4%
CIA
607
Covington Investment Advisors
Pennsylvania
$1.93M +$2.02M +13,698 New
RMCM
608
Reynders McVeigh Capital Management
Massachusetts
$1.93M +$52.3K +355 +3%
GL
609
GLG LLC
New York
$1.93M +$128K +868 +7%
IEFM
610
IQ EQ Fund Management
Ireland
$1.92M +$274K +1,857 +19%
PP
611
Paloma Partners
Connecticut
$1.91M +$2M +13,540 New
PAM
612
Princeton Alpha Management
New Jersey
$1.91M +$2M +13,544 New
PAG
613
Private Advisor Group
New Jersey
$1.9M +$296K +2,005 +18%
Cerity Partners
614
Cerity Partners
New York
$1.89M +$1.98M +13,416 New
MS
615
Marshall & Sullivan
Washington
$1.88M -$27K -183 -1%
SAM
616
Symphony Asset Management
California
$1.88M +$423K +2,869 +28%
GLA
617
Great Lakes Advisors
Illinois
$1.85M -$202K -1,370 -9%
TCOO
618
Trust Company of Oklahoma
Oklahoma
$1.85M -$287K -1,948 -13%
PWS
619
Peloton Wealth Strategists
Indiana
$1.84M -$103K -700 -5%
KRSITF
620
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$1.8M +$4.42K +30 +0.2%
BBI
621
Baxter Bros Inc
Connecticut
$1.79M +$25.2K +171 +1%
JGGDR
622
JGP Global Gestao de Recursos
Brazil
$1.79M +$461K +3,125 +33%
CAM
623
Carret Asset Management
New York
$1.79M +$108K +730 +6%
EHC
624
Everett Harris & Co
California
$1.79M
MERSOM
625
Municipal Employees' Retirement System of Michigan
Michigan
$1.78M +$25.1K +170 +1%

TMO Hedge Fund Activity: Q4 2016 in Review

1,113 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2016, worth a combined $48.7B — down 12% from $55.2B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 55 closed out — a net gain of 86 holders — while 388 added to existing stakes and 434 trimmed.

The largest buyer was Generation Investment Management, adding an estimated $246M. The largest seller was T. Rowe Price Associates, cutting an estimated $845M.

  • 1,113 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2016, up from 1,044 in Q3 2016.
  • Funds reported $48.7B of Thermo Fisher Scientific stock for Q4 2016, down 12% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q4 2016 and 55 closed out, a net change of +86 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2016 was Generation Investment Management, an estimated $246M added.
  • The largest Thermo Fisher Scientific seller in Q4 2016 was T. Rowe Price Associates, an estimated $845M sold.

Based on aggregated 13F filings for Q4 2016.